The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Tithi Ghosh et al.|PLoS ONE|2020Cited by 82
Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cellsSumati Gupta, S. Sharma, Alexis Weston et al.|Prostate Cancer and Prostatic Diseases|2016Cited by 47
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Jeffrey M. Trent et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 19
Abstract 3077: Preclinical studies of SR-8314, a highly selective ENPP1 inhibitor and an activator of STING pathwayAlexis Weston, Sunil Sharma, Trason Thode et al.|Cancer Research|2019Cited by 19
The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin β-Like 1-β-Catenin Protein ComplexRaffaella Soldi, Sunil Sharma, Tithi Ghosh et al.|Journal of Pharmacology and Experimental Therapeutics|2021Cited by 15